Rise and shine, everyone, another busy day has arrived. We can tell because the shortest of the short people dashed for the local schoolhouse and the official mascots have already finished their morning jog. As for us, we are already foraging for interesting items to pass along. Speaking of which, here are some tidbits. Hope your day builds to a successful crescendo and, as always, do keep us in mind when something fascinating occurs …
Drug makers say that the next Food and Drug Administration commissioner should have a medical background, and the agency should continue evaluating the effectiveness of new medicines, Bloomberg News writes. “If there is any attempt to change the mission of the FDA — in other words, to prove both safety and efficacy — then America’s primacy in drug discoveries will suffer,” warns Ovid Therapeutics chief executive officer Jeremy Levin.
Hmmm – “America’s primacy…. will suffer.”. Is there a chance he should have said ‘profits?’. If the FDA has less rigorous requirements, would the industry then be unable to justify their prices by pointing to the approval costs? Ah, ‘the unintended consequences’
We need someone with strong medical credentials. I hereby place in nomination the name of Frank N. Furter, MD for the position of next FDA Commissioner. He can’t be any worse than what they have now.
Comments are closed.